Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”

Xiao-Dong Zhou, Terry Cheuk-Fung Yip, Daniel Q Huang, Mark Dhinesh Muthiah, Mazen Noureddin, Ming-Hua Zheng

Clin Mol Hepatol. 2025;31(2):620-624. Published online December 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.1131

View: 1133 Download: 47 Crossref: 2

Original Article

The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease

Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah

Clin Mol Hepatol. 2022;28(3):565-574. Published online May 19, 2022

DOI: https://doi.org/10.3350/cmh.2022.0096

View: 9557 Download: 221 Web of Science: 58 Crossref: 60

Editorial

Direct-acting antiviral attained sustained virological response improve overall survival in patients with HCV-related hepatocellular carcinoma

Yan Ling Ong, Apichat Kaewdech, Daniel Q Huang, Yu Jun Wong

Received February 14, 2025 Accepted February 21, 2025

DOI: https://doi.org/10.3350/cmh.2025.0174 [Accepted]

View: 360 Download: 25

1 |

Viewed By 8481	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7419	MAFLD: How is it different from NAFLD?
Viewed By 5379	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5008	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4550	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 319	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 291	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search